Please use this identifier to cite or link to this item:
Title: Human immunodeficiency virus and hepatitis B or C co-infection in KwaZulu-Natal: a retrospective analysis of a laboratory database
Authors: Jinabhai, Champaklall 
Tathiah, Nerisha 
Parboosing, Raveen 
Singh, Lavanya 
Moodley, Pravi 
Keywords: Hepatitis;HIV;Hepatitis B;Hepatitis C;Co-infection;South Africa
Issue Date: 22-Aug-2013
Publisher: SAJEI
Source: Tathiah, N.; Parboosing, R.; Singh, L.; Jinabhai, C.C. and Moodley, P. 2014. Human immunodeficiency virus and hepatitis B or C co-infection in KwaZulu-Natal: a retrospective analysis of a laboratory database. Southern African Journal of Infectious Diseases;29(1):19-22
Journal: Corporate ownership & control (CD-ROM) 
Hepatitis B or C virus infection has an important influence on treatment and outcomes in human immunodeficiency virus (HIV)-infected individuals. HIV worsens the prognosis in hepatitis B- or C virus-infected patients, and patients on antiretroviral therapy are more likely to experience hepatotoxicity if they are co-infected with a hepatotropic virus. There is a paucity of data on the epidemiology of hepatotropic viruses in relation to each other and to HIV in KwaZulu-Natal. The aim of this study was to describe the seroprevalence of hepatitis B and C virus in HIV-positive and -negative individuals in KwaZulu-Natal from 2002-2010, using a large laboratory database of routine serological results. Patients who had an HIV or hepatitis B or C test performed at the National Health Laboratory Service Department of Virology in Durban from 2002-2010 were included in the study. The study revealed that the overall seropositivity of hepatitis B surface antigen (HBsAg) was 12.05%, and that of hepatitis C immunoglobulin G (IgG), 4.13%. Individuals who were seropositive for HIV had 3.19-fold increased odds of being positive for HBsAg, 2.06-fold increased odds of being hepatitis B virus e antigen-positive, and 2.91-fold increased odds of being hepatitis C virus IgG-positive. Of those individuals who were tested for HBsAg and hepatitis C virus IgG (irrespective of HIV status), 15.76% were seropositive for both markers. HIV-positive individuals are at increased odds of having markers for hepatitis B and C infection.
ISSN: 1015-8722
DOI: 10.1080/23120053.2014.11441561
Appears in Collections:Research Publications (Health Sciences)

Files in This Item:
File Description SizeFormat
jinabhai_et_al_2014.pdf170.38 kBAdobe PDFThumbnail
Show full item record

Page view(s)

checked on Jul 15, 2024


checked on Jul 15, 2024

Google ScholarTM




Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.